ICT&health December 1, 2021
Artur Olesch

Apps on prescriptions in Germany (DiGA) have their supporters and opponents. One year after introducing a novel legal framework, some celebrate 24 accepted digital health apps and 50.000 prescriptions. Others say the model is unsustainable – the share of DiGA prescriptions in the total number of prescriptions is 0,125%. What went wrong? We’ve talked to Sven Jungmann, a doctor by education and Chief Medical Officer and Partner at FoundersLane.

How do you evaluate the introduction of DiGA on the German healthcare market? What went well, and what went wrong?

Looking at the early versions of the official reasoning behind the DiGA, you will find that the people behind the DiGA initially were very soft on requirements regarding the evidence...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, Interview / Q&A, Patient / Consumer, Provider, Technology, Trends
AHRQ guide provides ways to support equity through digital health care technology
Clinicians, staff highlight strategies to enhance virtual diabetes care
Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances
Optum layoffs: naviHealth CEO out; Virtual care business shuttered
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired

Share This Article